Curavaleas SRL
2.2 FTECuravaleas reported total assets of 650,626 € at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Jul 2026), with 2.2 full-time equivalents.
The score of Curavaleas shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Curavaleas's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
Curavaleas's financial analysis
- Solvency4.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Curavaleas
Curavaleas's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1013.814.702
- VAT number
- BE1013814702
- Peppol
- Registered · 0208:1013814702 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Sep 2024
- Registered office
- 2660 Antwerp
- Size
- Micro · 2.2 FTE
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Curavaleas (SRL) has been based in Antwerp since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 5,437 € and equity of 27,607 €; its revenue is not published. With 2.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 4.2%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Curavaleas
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Cherain Retail sale of pharmaceutical products Gouvy · balance sheet 658,226 €
- Apotheek G. Burtin Retail sale of pharmaceutical products Tessenderlo-Ham · balance sheet 651,210 €
- Daluphar Retail sale of pharmaceutical products Anderlecht · balance sheet 651,365 €
- Raf BEX Retail sale of pharmaceutical products Leuven · balance sheet 651,970 €
- Apoteek Staes Retail sale of pharmaceutical products Diest · balance sheet 650,270 €
- Humbeek Pharma Retail sale of pharmaceutical products Grimbergen · balance sheet 653,604 €
- PharmaSil Retail sale of pharmaceutical products Antwerp · balance sheet 648,028 €
- Corum Mariakerke Retail sale of pharmaceutical products Ghent · balance sheet 666,044 €
Frequently asked questions about Curavaleas
What is the revenue of Curavaleas?
Curavaleas files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Curavaleas?
In Belgium, the VAT number is the company number prefixed with BE: BE1013814702 for Curavaleas, if the company is VAT-registered. Its company number (CBE) is 1013.814.702.
Where is the registered office of Curavaleas?
According to the CBE register, the registered office of Curavaleas is in 2660 Antwerp.
What is the equity of Curavaleas?
At the close of the 2025 financial year, the equity of Curavaleas amounts to 27,607 €, a solvency of 4.2% of total assets.
How many people work at Curavaleas?
2.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Curavaleas?
The register lists 2 active mandates at Curavaleas. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Curavaleas
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →